(Sunrise, FL) Bioheart, Inc released twelve-month data from its phase 1 ANGEL trial which is being conducted in Mexico.
Bioheart Announces Positive 12 Month Preliminary Data From Phase I Angel Trial (Market Wired)
Chief Science Officer Kristin Comella